- Home
- Publications
- Publication Search
- Publication Details
Title
Breakthroughs in Hepatocellular Carcinoma Therapies
Authors
Keywords
-
Journal
Clinical Gastroenterology and Hepatology
Volume 21, Issue 8, Pages 2135-2149
Publisher
Elsevier BV
Online
2023-02-21
DOI
10.1016/j.cgh.2023.01.039
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HCC Surveillance Improves Early Detection, Curative Treatment Receipt, and Survival in Patients with Cirrhosis: A Systematic Review and Meta-Analysis
- (2022) Amit G. Singal et al. JOURNAL OF HEPATOLOGY
- Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma
- (2022) Masatoshi Kudo et al. Liver Cancer
- 90Y Radioembolization versus Drug-eluting Bead Chemoembolization for Unresectable Hepatocellular Carcinoma: Results from the TRACE Phase II Randomized Controlled Trial
- (2022) Elisabeth Dhondt et al. RADIOLOGY
- Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial
- (2022) Ahmed Omar Kaseb et al. Lancet Gastroenterology & Hepatology
- Radiation segmentectomy for curative intent of unresectable very early to early stage hepatocellular carcinoma (RASER): a single-centre, single-arm study
- (2022) Edward Kim et al. Lancet Gastroenterology & Hepatology
- Hepatocellular carcinoma downstaging for liver transplantation in the era of systemic combined therapy with anti‐VEGF / TKI and immunotherapy
- (2022) Nguyen H. Tran et al. HEPATOLOGY
- Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial
- (2022) Robin Kate Kelley et al. LANCET ONCOLOGY
- TACE versus TARE for patients with hepatocellular carcinoma: Overall and individual patient level meta analysis
- (2022) Andrew M. Brown et al. Cancer Medicine
- Atezolizumab plus Bevacizumab Followed by Curative Conversion (ABC Conversion) in Patients with Unresectable, TACE-unsuitable Intermediate-stage Hepatocellular Carcinoma
- (2022) Masatoshi Kudo Liver Cancer
- Initiative on Superselective Conventional Transarterial Chemoembolization Results (INSPIRE)
- (2022) Thierry de Baere et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- NASH and Hepatocellular Carcinoma: Immunology and Immunotherapy
- (2022) Matthias Pinter et al. CLINICAL CANCER RESEARCH
- Low utilization of adult-to-adult LDLT in Western countries despite excellent outcomes: International multicenter analysis of the US, the UK, and Canada
- (2022) Tommy Ivanics et al. JOURNAL OF HEPATOLOGY
- Radiological endpoints as surrogates for survival benefit in Hepatocellular Carcinoma trials: all that glitters is not gold
- (2022) Giuseppe Cabibbo et al. JOURNAL OF HEPATOLOGY
- Pathogenesis of primary liver carcinomas
- (2022) Valérie Paradis et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma
- (2022) Arndt Vogel et al. LANCET
- Pembrolizumab Versus Placebo as Second-Line Therapy in Patients From Asia With Advanced Hepatocellular Carcinoma: A Randomized, Double-Blind, Phase III Trial
- (2022) Shukui Qin et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of Multidisciplinary Care in the Management of Hepatocellular Carcinoma
- (2021) Kia Byrd et al. SEMINARS IN LIVER DISEASE
- Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines
- (2021) A. Vogel et al. ANNALS OF ONCOLOGY
- International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma
- (2021) Amit G. Singal et al. GASTROENTEROLOGY
- End-points in clinical trials for liver cancer and their value in evidence based clinical decision making: an unresolved Gordian knot.
- (2021) Jordi Bruix JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis
- (2021) Victor Sapena et al. GUT
- Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable Hepatocellular Carcinoma: The LEGACY Study
- (2021) Riad Salem et al. HEPATOLOGY
- NASH limits anti-tumour surveillance in immunotherapy-treated HCC
- (2021) Dominik Pfister et al. NATURE
- Advances in immunotherapy for hepatocellular carcinoma
- (2021) Bruno Sangro et al. Nature Reviews Gastroenterology & Hepatology
- Dynamic α-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular Carcinoma
- (2021) Karim J. Halazun et al. JAMA Surgery
- Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update
- (2021) Masatoshi Kudo et al. Liver Cancer
- Downstaging Outcomes for Hepatocellular Carcinoma: Results From the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) Consortium
- (2021) Neil Mehta et al. GASTROENTEROLOGY
- CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis
- (2021) Masatoshi Kudo et al. JOURNAL OF HEPATOLOGY
- Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study
- (2021) Zhenggang Ren et al. LANCET ONCOLOGY
- Systemic treatment of hepatocellular carcinoma: An EASL position paper
- (2021) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- Baveno VII – Renewing consensus in portal hypertension
- (2021) Roberto de Franchis et al. JOURNAL OF HEPATOLOGY
- Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma
- (2021) Ann-Lii Cheng et al. JOURNAL OF HEPATOLOGY
- Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial
- (2021) Thomas Yau et al. LANCET ONCOLOGY
- Surgery Versus Radiofrequency Ablation for Small Hepatocellular Carcinoma: a Randomized Controlled Trial (SURF-Trial)
- (2021) Tadatoshi Takayama et al. Liver Cancer
- External Beam Radiation Therapy for Primary Liver Cancers: An ASTRO Clinical Practice Guideline
- (2021) Smith Apisarnthanarax et al. Practical Radiation Oncology
- BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
- (2021) Maria Reig et al. JOURNAL OF HEPATOLOGY
- Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients with Hepatocellular Carcinoma Presenting Beyond Milan Criteria
- (2020) Ani Kardashian et al. HEPATOLOGY
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements
- (2020) Masatoshi Kudo et al. Liver Cancer
- Local and Regional Therapies for Hepatocellular Carcinoma
- (2020) Roman Kloeckner et al. HEPATOLOGY
- Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial
- (2020) Vincenzo Mazzaferro et al. LANCET ONCOLOGY
- Conceptual Model for the Hepatocellular Carcinoma Screening Continuum: Current Status and Research Agenda
- (2020) Amit G. Singal et al. Clinical Gastroenterology and Hepatology
- Steatohepatitis Impairs T cell-directed Immunotherapies Against Liver Tumors in Mice
- (2020) Bernd Heinrich et al. GASTROENTEROLOGY
- PD‐1 inhibitor as bridge therapy to liver transplantation?
- (2020) Parissa Tabrizian et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial
- (2020) Etienne Garin et al. Lancet Gastroenterology & Hepatology
- Direct-Acting Antiviral Therapy not Associated with Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study
- (2019) Amit G. Singal et al. GASTROENTEROLOGY
- Live Donor Liver Transplantation for Patients with Hepatocellular Carcinoma Offers Increased Survival vs. Deceased Donation
- (2019) Nicolas Goldaracena et al. JOURNAL OF HEPATOLOGY
- Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Andrew X Zhu et al. LANCET ONCOLOGY
- Systematic review with meta-analysis: the critical role of dermatological events in patients with hepatocellular carcinoma treated with sorafenib
- (2019) Álvaro Díaz-González et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Direct-Acting Antiviral Therapy for HCV Infection is Associated with Increased Survival in Patients With a History of Hepatocellular Carcinoma
- (2019) Amit G. Singal et al. GASTROENTEROLOGY
- National Experience on Down‐staging of Hepatocellular Carcinoma before Liver Transplant: Influence of Tumor Burden, AFP , and Wait Time
- (2019) Neil Mehta et al. HEPATOLOGY
- Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC Guidelines) a 2019 update
- (2019) Norihiro Kokudo et al. HEPATOLOGY RESEARCH
- Insights into the success and failure of systemic therapy for hepatocellular carcinoma
- (2019) Jordi Bruix et al. Nature Reviews Gastroenterology & Hepatology
- Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child–Pugh A Liver Function: A Proof-Of-Concept Study
- (2019) Masatoshi Kudo et al. Cancers
- Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma
- (2019) Jens Ricke et al. JOURNAL OF HEPATOLOGY
- REFLECT—a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset
- (2019) Tatsuya Yamashita et al. JOURNAL OF GASTROENTEROLOGY
- Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
- (2019) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: A multi-institutional analysis of 1,010 patients
- (2019) Diamantis I. Tsilimigras et al. SURGERY
- Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma
- (2018) Vincenzo Mazzaferro et al. GASTROENTEROLOGY
- Diagnosis, Staging and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
- (2018) Jorge A. Marrero et al. HEPATOLOGY
- Hepatic resection compared to chemoembolization in intermediate- to advanced-stage hepatocellular carcinoma: A meta-analysis of high-quality studies
- (2018) Myung Han Hyun et al. HEPATOLOGY
- Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma in Nonsurgically Managed Patients: Analysis of the National Cancer Database
- (2018) Devalkumar J. Rajyaguru et al. JOURNAL OF CLINICAL ONCOLOGY
- SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
- (2018) Pierce K.H. Chow et al. JOURNAL OF CLINICAL ONCOLOGY
- Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations
- (2018) Jean-Charles Nault et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Effectiveness and cost of radiofrequency ablation and stereotactic body radiotherapy for treatment of early-stage hepatocellular carcinoma: An analysis of SEER-medicare
- (2018) Neehar D Parikh et al. Journal of Medical Imaging and Radiation Oncology
- Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
- (2018) Sheng-Nan Lu et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study
- (2018) Lorenza Rimassa et al. LANCET ONCOLOGY
- Pilot study of living donor liver transplantation for patients with hepatocellular carcinoma exceeding Milan Criteria (Barcelona Clinic Liver Cancer extended criteria)
- (2018) Josep M. Llovet et al. LIVER TRANSPLANTATION
- Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
- (2018) Ghassan K. Abou-Alfa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases
- (2018) Jonathan G. Stine et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- OUP accepted manuscript
- (2018) ANNALS OF ONCOLOGY
- Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection
- (2018) Anthony W.H. Chan et al. JOURNAL OF HEPATOLOGY
- Meta-analysis of short- and long-term outcomes after pure laparoscopic versus open liver surgery in hepatocellular carcinoma patients
- (2018) Jan Witowski et al. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
- A Systematic Review and Meta-Analysis Comparing the Short- and Long-Term Outcomes for Laparoscopic and Open Liver Resections for Hepatocellular Carcinoma: Updated Results from the European Guidelines Meeting on Laparoscopic Liver Surgery, Southampton, UK, 2017
- (2018) Ruben Ciria et al. ANNALS OF SURGICAL ONCOLOGY
- Alpha‐fetoprotein Decrease from >1000 to
- (2018) Neil Mehta et al. HEPATOLOGY
- Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis
- (2017) Laura Kulik et al. HEPATOLOGY
- Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis
- (2017) Gonzalo Sapisochin et al. JOURNAL OF HEPATOLOGY
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
- (2017) Valérie Vilgrain et al. LANCET ONCOLOGY
- The extended Toronto criteria for liver transplantation in patients with hepatocellular carcinoma: A prospective validation study
- (2016) Gonzalo Sapisochin et al. HEPATOLOGY
- Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion
- (2016) Takashi Kokudo et al. JOURNAL OF HEPATOLOGY
- Hierarchic Interaction of Factors Associated With Liver Decompensation After Resection for Hepatocellular Carcinoma
- (2016) Davide Citterio et al. JAMA Surgery
- Recurrence of Hepatocellular Cancer After Resection
- (2015) Parissa Tabrizian et al. ANNALS OF SURGERY
- Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: A systematic review and meta-analysis
- (2015) Annalisa Berzigotti et al. HEPATOLOGY
- Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
- (2015) Jordi Bruix et al. LANCET ONCOLOGY
- Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib
- (2014) Andrew X. Zhu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Early dermatologic adverse events predict better outcome in HCC patients treated with sorafenib
- (2014) Maria Reig et al. JOURNAL OF HEPATOLOGY
- Transarterial Chemoembolization Failure/Refractoriness: JSH-LCSGJ Criteria 2014 Update
- (2014) Masatoshi Kudo et al. ONCOLOGY
- Efficacy of Sorafenib in Intermediate-Stage Hepatocellular Carcinoma Patients Refractory to Transarterial Chemoembolization
- (2014) Sadahisa Ogasawara et al. ONCOLOGY
- Validation of the Criteria of Transcatheter Arterial Chemoembolization Failure or Refractoriness in Patients with Advanced Hepatocellular Carcinoma Proposed by the LCSGJ
- (2014) Tadaaki Arizumi et al. ONCOLOGY
- Above 5 cm, Size Does Not Matter Anymore in Patients with Hepatocellular Carcinoma
- (2014) Chetana Lim et al. WORLD JOURNAL OF SURGERY
- How to Define Transarterial Chemoembolization Failure or Refractoriness: A European Perspective
- (2014) Jean-Luc Raoul et al. Liver Cancer
- Establishment of a Multidisciplinary Hepatocellular Carcinoma Clinic is Associated with Improved Clinical Outcome
- (2013) Adam C. Yopp et al. ANNALS OF SURGICAL ONCOLOGY
- Postprogression survival of patients with advanced hepatocellular carcinoma: Rationale for second-line trial design
- (2013) Maria Reig et al. HEPATOLOGY
- Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study
- (2013) Josep M. Llovet et al. JOURNAL OF CLINICAL ONCOLOGY
- Re-evaluating transarterial chemoembolization for the treatment of Hepatocellular Carcinoma: Consensus recommendations and review by an International Expert Panel
- (2013) Ann Lii Cheng et al. LIVER INTERNATIONAL
- Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria
- (2012) Christophe Duvoux et al. GASTROENTEROLOGY
- Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design
- (2012) Marta Burrel et al. JOURNAL OF HEPATOLOGY
- Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version
- (2011) Masatoshi Kudo et al. DIGESTIVE DISEASES
- Clinical decision making and research in hepatocellular carcinoma: Pivotal role of imaging techniques
- (2011) Jordi Bruix et al. HEPATOLOGY
- Multifaceted perspective of the waiting list for liver transplantation: The value of pharmacokinetic models
- (2009) Miquel Navasa et al. HEPATOLOGY
- Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
- (2008) Vincenzo Mazzaferro et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More